Granzyme B/GZMB Protein, Human, Recombinant (His)

Artikelnummer: TGM-TMPY-00817
Artikelname: Granzyme B/GZMB Protein, Human, Recombinant (His)
Artikelnummer: TGM-TMPY-00817
Hersteller Artikelnummer: TMPY-00817
Alternativnummer: TGM-TMPY-00817-5UG,TGM-TMPY-00817-10UG,TGM-TMPY-00817-20UG,TGM-TMPY-00817-50UG,TGM-TMPY-00817-100UG,TGM-TMPY-00817-200UG,TGM-TMPY-00817-500UG
Hersteller: TargetMol
Kategorie: Biochemikalien
Alternative Synonym: CGL1 , CTLA1 , CSP-B , CTSGL1 , HLP , SECT , CSPB , granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) , CCPI , CGL-1
Granzyme B, also known as GZMB, is the most prominent member of the granzyme family of cell death-inducing serine proteases expressed in the granules of cytotoxic T lymphocytes (CTLs) and NK cells. Granzyme B enters the target cells depending on another membrane-binding granule protein, perforin, results in the activation of effector caspases and mitochondrial depolarization through caspase-dependent and -independent pathways, and consequently induces rapid cell apoptosis. Over 3 substrates of GZMB have been identified including the key substrate caspase-3, ICAD, and Bid. GZMB is suggested to protect the host by lysing cells bearing on their surface nonself antigens such as bacterial and viral infected-cells and tumor cells and accordingly plays an essential role in immunosurveillance.
Molekulargewicht: 27.2 kDa (predicted), 35-40 kDa (reducing condition, due to glycosylation)
Reinheit: 98.00%
TMPY-00817